About

The company was incorporated in 1982 and was originally known Remee Holding Sdn Bhd ("Remee"). In 1989, after securing a successful bid for the privatization of the Veterinary Research Institute of Malaysia (VRI) vaccines production unit, it also bid to commercialize the University Putra Malaysia (UPM)'s Newcastle Disease vaccine. It won bids on condition tha Remee build its own vaccine plant within 18 months of securing the bids.

To date, besides domestic sales in Malaysia, MVP's products are available throughout Asia and Africa covering a wide range of countries. Besides ASEAN, other markets include Hong Kong, Iran, Pakistan, Nepal, Egypt and Qatar. MVP also supplied its vaccines to the following countries through FAO and UNDP such as India, Bangladesh, Ghana, Angola, Nigeria, Kenya, Sudan, Ivory Coast, Zimbabwe, Zambia and Mauritius. Recently, MVP has successfully secured an approval from Japan's Ministry of Agriculture, Food and Feed to export its vaccines into the country. MVP continued embarking its journey to open more markets by participating in many international trade events, seminars and major exhibitions like VIV ASIA, VIV Middle East and Africa, VICTAM Bangkok, Livestock Philippines, Livestock Indo and Dubai 2020. Branding is the main focus in its marketing strategy and MVP has successfully positioned itself as an affordable and competitive brand without compromising its product quality and efficacy.

Product Category

Video (SAMPLE - This is just for your reference only!)

(Keyboard shortcut to open full screen in Youtube video - Press "F" button)